RT Journal Article
SR Electronic
T1 Interventions in sexual and reproductive health services addressing violence against women in low- and middle- income countries: a mixed-methods systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.18.21266456
DO 10.1101/2021.11.18.21266456
A1 Lewis, Natalia V
A1 Munas, Muzrif
A1 Colombini, Manuela
A1 d’Oliveira, Ana Flavia
A1 Pereira, Stephanie
A1 Shrestha, Satya
A1 Rajapakse, Thilini
A1 Shaheen, Amira
A1 Rishal, Poonam
A1 Alkaiyat, Abdulsalam
A1 Richards, Alison
A1 García-Moreno, Claudia M
A1 Feder, Gene S
A1 Bacchus, Loraine J
YR 2021
UL http://medrxiv.org/content/early/2021/11/18/2021.11.18.21266456.abstract
AB Objectives To synthesise evidence on the effectiveness, cost-effectiveness, and barriers to responding to violence against women (VAW) in sexual and reproductive health (SRH) services in low- and middle-income countries (LMICs).Design Mixed-methods systematic review.Data sources Medline, Embase, Psycinfo, Cochrane, Cinahl, IMEMR, Web of Science, Popline, Lilacs, WHO RHL, ClinicalTrials.gov, Google, Google Scholar, websites of key organisations through December 2019.Eligibility criteria Studies of any design that evaluated VAW interventions in SRH services in LMICs.Data extraction and synthesis Concurrent narrative quantitative and thematic qualitative syntheses, integration through line of argument and mapping onto a logic model. Two reviewers extracted data and appraised quality.Results 26 studies of varied interventions using heterogeneous outcomes. Of ten interventions that strengthened health systems capacity to respond to VAW during routine SRH consultation, three reported no harm and reduction in some types of violence. Of nine interventions that strengthened health systems and communities’ capacity to respond to VAW, three reported conflicting effects on re-exposure to some types of VAW and mixed effect on SRH. The interventions increased identification of VAW but had no effect on the provision (75-100%) and uptake (0.6-53%) of referrals to VAW services. Of seven psychosocial interventions in addition to SRH consultation that strengthened women’s readiness to address VAW, four reduced re-exposure to some types of VAW and improved health. Factors that disrupted the pathway to better outcomes included accepting attitudes towards VAW, fear of consequences, and limited readiness of the society, health systems, and individuals. No study evaluated cost-effectiveness.Conclusions Some VAW interventions in SRH services reduced re-exposure to some types of VAW and improved some health outcomes in single studies. Future interventions should strengthen capacity to address VAW across health systems, communities, and individual women. First-line support should be better tailored to women’s needs and expectations.PROSPERO protocol CRD42019137167.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=137167 Funding StatementThis research was funded by the National Institute for Health Research (NIHR) (17/63/125) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK government. AR was funded by the NIHR Applied Research Collaboration West (NIHR ARC West). The views expressed in this article are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.